Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2020 Jul 25;223:192–198. doi: 10.1016/j.schres.2020.07.018

COVID-19 lockdown in people with severe mental disorders in Spain: Do they have a specific psychological reaction compared with other mental disorders and healthy controls?

Leticia González-Blanco a,b,c,d,e,1, Francesco Dal Santo a,b,d,e,1, Leticia García-Álvarez b,c,d,e,f,, Lorena de la Fuente-Tomás b,c,d,e, Carlota Moya Lacasa a, Gonzalo Paniagua a, Pilar A Sáiz a,b,c,d,e, María Paz García-Portilla a,b,c,d,e, Julio Bobes a,b,c,d,e
PMCID: PMC7381938  PMID: 32771308

Abstract

The COVID-19 pandemic and the lockdown restrictions could have adverse consequences for patients with severe mental disorders (SMD). Here, we aim to compare the early psychological impact (depression, anxiety, and stress responses, intrusive and avoidant thoughts, and coping strategies) on people with SMD (n = 125) compared with two control groups: common mental disorders (CMD, n = 250) and healthy controls (HC, n = 250).

An anonymous online questionnaire using a snowball sampling method was conducted from March 19–26, 2020 and included sociodemographic and clinical data along with the DASS-21 and IES scales. We performed descriptive and bivariate analyses and multinomial and linear regression models.

People with SMD had higher anxiety, stress, and depression responses than HC, but lower scores than CMD in all domains. Most people with SMD (87.2%) were able to enjoy free time, although control groups had higher percentages. After controlling for confounding factors, anxiety was the only significant psychological domain with lower scores in HC than people with SMD (OR = 0.721; 95% CI: 0.579–0.898). In the SMD group, higher anxiety was associated with being single (beta = 0.144), having COVID-19 symptoms (beta = 0.146), and a higher score on the stress subscale of DASS-21 (beta = 0.538); whereas being able to enjoy free time was a protective factor (beta = −0.244).

Our results showed that patients with SMD reacted to the pandemic and the lockdown restrictions with higher anxiety levels than the general public, and suggesting this domain could be a criterion for early intervention strategies and closer follow-up.

Keywords: COVID-19, Pandemics, Bipolar disorder, Psychosis, Psychological distress, Anxiety

1. Introduction

After the outbreak of a new coronavirus subtype SARS-CoV-2 in China in late 2019, a global pandemic developed, generating a health, economic, and social emergency (Wang et al., 2020a). In Spain, the first case of COVID-19 disease was reported in February, and since that time, there has been an exponential increase in the number of people infected. Consequently, a state of emergency was declared and a strict lockdown order was issued on March 14, 2020 to reduce the spread of the virus.

Previous literature has provided evidence of the negative psychological impact that epidemic outbreaks have on the general population (Lam et al., 2009). Multiple concurrent factors can contribute to increased fear or anxiety, including the physical distancing and self-isolation strategies used to contain the spread of the infectious agent (Brooks et al., 2020). Recent studies during the COVID-19 outbreak have reported early emotional distress in more than half of the general public surveyed in China (Lima et al., 2020; Wang et al., 2020b), and rates may be higher in vulnerable population groups (Pfefferbaum and North, 2020). García-Álvarez et al. (2020a) examined the early impact of the COVID-19 pandemic and lockdown on mental health in a large sample of the Spanish population. They found that people reporting a current mental disorder were experiencing the greatest psychological impact, followed by those reporting a past mental disorder. Both groups experienced a stronger psychological impact than the general population. It should be noted that most of these people had symptoms of common mental disorders such as anxiety or depression.

In people with severe mental illnesses, psychological stress and adverse life experiences have been recognized as risk factors for psychosis onset and relapse (Fusar-Poli et al., 2017). Moreover, this population may be particularly exposed to stress and physical distancing measures (Brown et al., 2020; Druss, 2020) and thus disproportionately vulnerable to public health interventions to fight the COVID-19 pandemic (Kozloff et al., 2020). However, far too little attention has been paid to these patients and, to our knowledge, there are no specific data about the emotional distress caused by the current pandemic and lockdown restrictions in this population. One study during the SARS epidemic showed that psychiatric inpatients had more anxiety than the staff and the same dysphoria (Iancu et al., 2005).

Thus, the main objectives of this study are (1) to compare early psychological impact in people with severe mental illness and two control groups (commo mental disorders and healthy controls) and (2) identify the risk and protective factors associated with a maladaptative psychological response.

2. Methods

2.1. Study design

We performed a secondary analysis of a larger cross-sectional study exploring the early psychological impact of the COVID-19 pandemic and the lockdown restrictions in a sample of 21,279 people living in Spain (García-Álvarez et al., 2020a). It consisted of an anonymous online questionnaire conducted from March 19–26, 2020, five days after the official declaration of a state of emergency and issuance of the lockdown order. A virtual snowball sampling recruitment strategy was used. Inclusion criteria were 1) being older than 17 years (72 participants excluded) and 2) giving informed consent (for more details, see García-Álvarez et al., 2020a).

The Clinical Research Ethics Committee of Hospital Universitario Central de Asturias in Oviedo, Spain approved the study protocol (Ref. 2020.162), and online informed consent was obtained from all participants before enrolment. The study followed the ethical principles of the Declaration of Helsinki (World Medical Association General Assembly, 2013).

2.2. Participants

To accomplish the aims of the present study, we analyzed a subset of the original sample. People were asked if they had past or current mental health problems (yes/no questions) as well as the type of mental disorder (anxiety, depression, psychotic and bipolar disorders). On that basis, a total of 625 people was included. Of those, 125 had severe mental disorders consisting of 65 cases of bipolar disorder (BD) and 60 of psychotic disorders (severe mental disorder group – SMD), 250 had other current mental disorders consisting of 125 cases of depression and 125 of anxiety (common mental disorder control group – CMD), and 250 had no current or past mental disorders (healthy control group – HC). Subjects in each of the two control groups were matched (ratio 1:2) for sex and age (± 1 year) with the SMD group and, in most cases, also for geographic area (χ2 = 223,586, p = .676). Geographic area distribution for each group is presented in Table 1 of the Supplementary Material. In addition, as the psychological impact changed from day to day and was affected by a further 14-day extension of the lockdown on March 22 (García-Álvarez et al., 2020a), we matched the groups for the two periods of pandemic (March 19–22 and 23–26) in almost all cases (see Table 1).

Table 1.

Sociodemographic and clinical characteristics of the study sample groups.

Severe Mental Disorder
N = 125
Common Mental Disorder
N = 250
Healthy Control
N = 250
Statistical test, P;
Post Hoc P
Age [Mean (SD)] 43.25 (14.41) 43.17 (14.27) 43.27 (14.37) F = 0.003, 0.997
Sex, female [n (%)] 77 (61.6%) 154 (61.6%) 154 (61.6%) χ2 = 0.000, 1.000
Marital status χ2 = 5.485, 0.241
 Never married 62 (49.6%) 108 (43.2%) 100 (40.0%)
 Married/Living as married 46 (36.8%) 107 (42.8%) 122 (48.8%)
 Separated/Divorced/Widowed 17 (13.6%) 35 (14.0%) 28 (11.2%)
Education level [n (%)] χ2 = 4.858, 0.088
 Primary/Secondary 52 (41.6%) 121 (48.4%) 97 (38.8%)
 University 73 (58.4%) 129 (51.6%) 153 (61.2%)
Work status [n (%)] χ2 = 29.863, <0.001;
 Unemployed 18 (14.4%) 25 (10.0%) 16 (6.4%) a 0.005
 Working 49 (39.2%) 146 (58.4%) 170 (68.0%) b < 0.001
 Retired 27 (21.6%) 32 (12.8%) 25 (10.0%) c > 0.05
 Student/Homemaker/Other 31 (24.8%) 47 (18.8%) 39 (15.6%)
Income (€) [n (%)] χ2 = 17.959, 0.006;
 No income or less than 500 37 (29.6%) 50 (20.0%) 43 (17.2%) b 0.002
 500–1499 46 (36.8%) 91 (36.4%) 73 (29.2%) a, c > 0.05
 More than 1500 37 (29.6%) 91 (36.4%) 119 (47.6%)
 Prefer not to answer 5 (4%) 18 (7.2%) 15 (6%)
Change in work status due to COVID-19 [n (%)] χ2 = 9.253, 0.160
 No 107 (87.74%) 207 (83.5%) 201 (81.4%)
 ETLA/EPLO# 6 (4.9%) 29 (11.7%) 25 (10.1%)
 Termination 2 (1.6%) 6 (2.4%) 5 (2.0%)
 Furlough 7 (5.7%) 6 (2.4%) 16 (6.5%)
Change in income due to COVID-19 [n (%)] χ2 = 9.030, 0.340
 No 96 (76.8%) 179 (71.6%) 188 (75.2%)
 Reduction, up to 25% 11 (8.8%) 20 (8.0%) 25 (10.0%)
 Reduction, 26–50% 9 (7.2%) 21 (8.4%) 19 (7.6%)
 Reduction, 51–100% 9 (7.2%) 30 (12.0%) 16 (6.4%)
 Increase 0 (0.0%) 0 (0.0%) 2 (0.8%)
Living situation [n (%)] χ2 = 9.886, 0.042;
 Alone 27 (21.6%) 46 (18.4%) 37 (14.8%) b 0.008
 Two people 56 (44.8%) 95 (38.0%) 87 (34.8%) a, c > 0.05
 More than three 42 (33.6%) 109 (43.6%) 126 (50.4%)
Dependent children [n (%)] χ2 = 17.709, 0.001
 None 103 (82.4%) 168 (67.2%) 163 (65.2%) a 0.008
 One 13 (10.4%) 51 (20.4%) 40 (16.0%) b 0.002
 Two or more 9 (7.2%) 31 (12.4%) 47 (18.0%) c > 0.05
Elderly dependents [n (%)] χ2 = 3.689, 0.450
 None 108 (86.4%) 214 (85.6%) 221 (88.4%)
 One 14 (11.2%) 23 (9.2%) 17 (6.8%)
 Two or more 3 (2.4%) 13 (5.2%) 12 (4.8%)
Current physical disease, Yes 62 (63.3%) 116 (52.3%) 48 (20.5%) χ2 = 72.408, <0.001
Tested for COVID-19 χ2 = 9.010, 0.173
 No 124 (99.2%) 245 (98.0%) 248 (99.6%)
 Yes, negative 0.0 (0.0%) 4 (1.6%) 1 (0.4%)
 Yes, results pending 1 (0.8%) 0 (0.0%) 0 (0.0%)
 Yes, positive 0 (0.0%) 1 (0.4%) 0 (0.0%)
COVID-19 symptoms, Yes 18 (14.4%) 34 (13.6%) 24 (9.6%) χ2 = 2.606, 0.272
Family/Friends infected
with COVID-19, Yes
24 (19.40%) 49 (19.7%) 42 (16.9%) χ2 = 0.691, 0.708
Living with people infected
with COVID-19, Yes
5 (4.0%) 7 (2.8%) 3 (1.2%) χ2 = 3.074, 0.215
Survey response period χ2 = 0.396, 0.821
March 19–22 68 (54.4%) 143 (57.2%) 137 (54.8%)
March 23–26 57 (45.6%) 107 (42.8%) 113 (45.2%)
#

ETLA: Employee Temporary Lay Off. EPLO: Employee Permanent Lay Off.

Physical disease includes hypertension, diabetes, cardiovascular diseases, respiratory diseases (asthma, COPD, etc.), and cancer.

a

Comparison between Severe Mental Disorder (SMD) vs. Common Mental Disorder (CMD).

b

SMD vs. Healthy Controls (HC).

c

CMD vs. HC.

2.3. Assessments

The assessment consisted of an ad hoc online questionnaire and the Spanish versions of the Depression, Anxiety, and Stress Scale (DASS-21) (Bados et al., 2005) and the Impact of Event Scale (IES) (Báguena et al., 2001). The ad hoc questionnaire included sociodemographic and clinical data such as age, sex, province of residence, education, marital status, living arrangement, work status, monthly income, changes in work status due to COVID-19, changes in monthly income due to COVID-19, number and age of dependent children, and dependent older adults. Clinical variables included current medical conditions and past/current mental disorders. The survey also included questions about engaging in different leisure activities during the lockdown (exercise; watching movies or television programs; reading or watching news about COVID-19; drawing, writing, reading, or listening to music; cooking; using social networks; drinking alcohol; smoking tobacco; smoking other illicit substances; working; and doing yoga or meditation) (for more details, see García-Álvarez et al., 2020a).

To measure the psychological impact of COVID-19 and maladaptive responses, we employed the self-rated DASS-21 and IES scales. The DASS-21 provided scores (range 0–7) on three subscales: depression, anxiety, and stress, while the IES provided scores (0–7 and 0–8) on two subscales: intrusion (intrusive thoughts) and avoidance (avoidant thoughts). Subjects were asked to report whether they had experienced any of the psychological symptoms mentioned in the questionnaires during the last week. Higher scores on the five subscales meant greater distress. We adopted a binary response solution (yes/no) for the scale items to simplify the survey and promote a more inclusive and user-friendly experience (García-Álvarez et al., 2020a).

2.4. Data analysis

Statistical analyses were performed using the software package IBM SPSS Statistics for Windows, Version 23.0. Significance levels were set at p < .05. Univariate and bivariate analysis was performed on all variables, and data were expressed as percentages or means and standard deviations (SD). Differences among groups for continuous data were analyzed using a one-way analysis of variance (ANOVA) and least significant difference (LSD) post hoc test, while the chi-square test was used for categorical variables.

To identify the specific psychological COVID-19 response of the people with SMD, we performed a multinomial logistic regression, using the SMD group as the reference group. In the regression, as independent predictors we included each variable that demonstrated significant differences among the three groups in the bivariate analysis. The possible existence of multicollinearity among the included variables was discarded before carrying out the analysis. Our second objective concerned exclusively the psychological dimensions that constituted the specific phenotype of the people with SMD, i.e., the anxiety response. We initially performed bivariate analyses to identify the variables significantly associated with it. Then, we included all the identified variables in a multiple linear regression model to determine the risk and protective factors of the anxiety response to COVID-19 in people with SMD.

3. Results

3.1. Sociodemographic and clinical characteristics of SMD

The mean age of the SMD group was 43.25 (SD = 14.41) years, and 77 (61.6%) were women. Almost 50% were never married, and 58.4% were people with a university education. As expected, a lower percentage of people with SMD were working (39.2%) compared with the other two control groups, and a higher proportion of people with SMD had no income or less than 500 € a month (29.6%). A total of 78.4% were living with other people, and most of them reported not having dependent older adults or children. It should be noted that more than 60% of people with SMD had a current physical disease, which was significantly higher than in the HC group. At the time of the assessment, a small group of people with SMD presented self-reported symptoms of COVID-19 (14.4%), were living with infected people (4%), or had family or friends with the illness (19.4%). Additional data on sociodemographic and clinical aspects are presented in Table 1.

Regarding leisure activities, the majority of people with SMD were able to enjoy free time, although the highest percentage was among HC (87.2% vs. 94.7%, p = .022) (see Table 2 ). Their preferred activity was watching television, followed by using social networks, and painting or listening to music (all of them engaged in by more than 84% of people). By contrast, using illicit drugs (7.2%) and drinking alcohol (15.2%) represented the lowest percentages in all groups, and there were no differences between groups.

Table 2.

Lockdown leisure activities of the study sample groups.

Severe Mental Disorder
N = 125
Common Mental Disorder
N = 250
Heathy Control
N = 250
Statistical test, P; Post Hoc P
Able to enjoy free time, Yes 109 (87.2%) 200 (80.0%) 235 (94.0%) χ2 = 27.480, <0.001; b 0.022 c < 0.001
Doing exercise, Yes 63 (50.4%) 99 (39.6%) 147 (58.8%) χ2 = 18.492, <0.001; a 0.047 c < 0.001
Yoga/Meditation, Yes 37 (29.6%) 66 (26.4%) 49 (19.6%) χ2 = 5.507, 0.064; b 0.030
Watching TV, Yes 107 (85.6%) 200 (80.0%) 223 (89.2%) χ2 = 8.286, 0.016; c 0.004
Reading COVID news, Yes 89 (64.0%) 146 (58.4%) 176 (70.4%) χ2 = 7.850, 0.020; c 0.005
Painting/Listening to music, Yes 105 (84.0%) 190 (76.0%) 216 (86.4%) χ2 = 9.592, 0.008; c 0.003
Cooking, Yes 66 (52.8%) 143 (57.2%) 175 (70.0%) χ2 = 13.568, 0.001; b 0.001c 0.003
Social networks, Yes 106 (84.8%) 217 (86.8%) 234 (93.6%) χ2 = 8.968, 0.011; b 0.006 c 0.011
Working, Yes 43 (34.4%) 109 (43.6%) 157 (62.8%) χ2 = 32.574, <0.001; b < 0.001c < 0.001
Smoking, Yes 30 (32.0%) 59 (23.6%) 46 (18.4%) χ2 = 8.688, 0.013; b 0.003
Drinking, Yes 19 (15.2%) 48 (19.2%) 37 (14.8%) χ2 = 1.978, 0.372
Illicit drug use, Yes 9 (7.2%) 12 (4.8%) 9 (3.6%) χ2 = 2.363, 0.307
a

Comparison between Severe Mental Disorder (SMD) vs. Common Mental Disorder (CMD).

b

SMD vs. Healthy Controls (HC).

c

CMD vs. HC.

When compared with the CMD group, a significantly higher proportion of people with SMD engaged in exercise (CMD = 39.6% vs SMD = 50.4%, p = .047). On the other hand, compared with HC, people with SMD more often practiced meditation or yoga (HC = 19.6% vs. SMD = 29.6%, p = .030), but less often activities such as cooking, using social networks, or working. Tobacco use as a coping method was more frequently observed among people with SMD compared with HC.

3.2. Early psychological impact of the COVID-19 pandemic and lockdown on people with SMD compared with control groups

The bivariate analyses comparing the three groups (Table 3 ) showed that people with SMD had statistically significantly higher scores on anxiety, stress, and depression subscales of the DASS-21 compared with the HC group, but lower scores compared with the CMD group (all p < .05). Regarding IES subscales, people with SMD had lower intrusive thoughts and avoidance scores compared with the CMD group but no differences compared with the HC group (Table 3).

Table 3.

Psychological impact on the study sample groups.

Severe Mental Disorder
N = 125
Common Mental Disorder
N = 250
Heathy Control
N = 250
Statistical test, P; Post Hoc P
DASS-21
 Depression subscale 3.96 (1.19) 4.26 (1.40) 3.59 (1.04) F = 18.850, <0.001; a 0.026 b 0.006 c < 0.001
 Anxiety subscale 1.77 (1.86) 2.38 (2.15) 0.92 (1.29) F = 42.201, <0.001; a 0.001 b < 0.001 c < 0.001
 Stress subscale 2.76 (2.60) 3.57 (2.52) 2.19 (2.30) F = 20.050, <0.001; a 0.003 b 0.034 c < 0.001
IES
 Intrusive thoughts subscale 2.40 (2.00) 3.02 (2.31) 1.96 (1.87) F = 16.401, <0.001; a 0.006 c < 0.001
 Avoidance subscale 2.32 (1.99) 4.10 (2.09) 3.14 (2.03) F = 14.846, <0.001; a 0.001 c < 0.001

DASS-21: Depression, Anxiety, and Stress Scale; IES: Impact of Event Scale.

a

Comparison between Severe Mental Disorder (SMD) vs. Other Mental Disorder (CMD).

b

SMD vs. Healthy Controls (HC).

c

CMD vs. HC.

In the next analysis step, all variables with statistically significant differences among the three groups (work status, income, living situation, dependent children, current physical disease, several leisure activities, and DASS-21 and IES subscale scores) were included in the multinomial logistic regression along with education level (p = .088). The results of this regression showed that COVID-19 was associated with a more intense anxiety response in people with SMD compared with HC [B = −0.327, p = .004; OR (95% CI) = 0.721 (0.579–0.898)]. No differences in psychological impact were observed between SMD and CMD groups. Table 4 shows the B coefficient, p-value, and odds ratio (OR) (95% CI) of every potential statistically significant predictive variable that was included in the model.

Table 4.

Results from the multinomial regression model. Reference Category: “Group of people with Severe Mental Disorder”.

B OR (95% CI) P
Common Mental Disorder
Intercept 1.467 0.092
Physical disease, reference: Yes −0.676 0.509 (0.304; 0.851) 0.010
Income (€), reference: More than 1500
No income or less than 500 −0.956 0.385 (0.156; 0.946) 0.037
500–1499 −0.621 0.537 (0.290; 0.995) 0.048
Healthy Control
Intercept 2.033 0.039
Anxiety subscale of DASS-21 −0.327 0.721 (0.579; 0.898) 0.004
Cooking, reference: Yes 0.752 2.121 (1.231; 3.652) 0.007
Mediation/Yoga, reference: Yes −0.759 0.468 (0.250; 0.877) 0.018
Working, reference: Yes 0.721 2.056 (1.182; 3.576) 0.011
Smoking, reference: Yes −0.775 0.461 (0.252; 0.841) 0.012
Physical disease, reference: Yes −2.027 0.132 (0.076; 0.228) <0.001

OR: odds ratio; 95% CI: 95% confidence interval.

Only statistically significant associations are shown.

3.3. Risk and protective factors of the anxiety response to the COVID-19 pandemic and lockdown in people with SMD

Age was negatively correlated with the anxiety subscore (r = −0.295, p = .001), but no differences by sex were observed (p > .05). Regarding other sociodemographic characteristics, differences were found based on marital status (F = 6.494, p = .002), work status (F = 5.134, p = .002), income (F = 4.454, p = .005), living situation (F = 4.285, p = .016) and having dependent children (t = −4.328, p < .001). Higher scores were found on the anxiety subscale in people with SMD who were never married, were students, had monthly income less than 500, lived alone, and had no dependent children. No differences were found for education level, change in work status or income, or having elderly dependents.

There were also no differences in the anxiety response in people with SMD and underlying physical conditions, but higher anxiety levels were experienced by those who reported COVID-19 symptoms (t = 2.580, p = .018) or had infected family or friends (t = 2.258, p = .031).

Higher scores on the anxiety subscale were also positively correlated with scores on the DASS-21 depression and stress subscales (r = 0.524, p < .001; r = 0.713, p < .001) and scores on the IES intrusive thoughts and avoidance subscales (r = 0.545, p < .001; r = 0.487, p < .001). Finally, people who were able to enjoy free time had a lower anxiety response [mean 1.38 (SD = 1.63) vs 4.00 (SD = 1.71), t = 5.969, p < .001]. However, engaging in specific activities during lockdown had no effect on anxiety scores.

Considering all potential confounders, the multiple linear regression model (R2 = 0.580, F = 41.027, p < .001) detected being single (beta = 0.144, t = 2.291, p = .024), having symptoms of COVID-19 (beta = 0.146, t = 2.395, p = .018), and higher scores on the DASS-21 stress subscale (beta = 0.538, t = 7.635, p < .001) as risk factors for anxiety response in people with SMD; whereas a protective effect was associated with being able to enjoy free time (beta = −0.244, t = −3.692, p < .001).

4. Discussion

To our knowledge, this is the first study to explicitly examine the early psychological impact (depression, anxiety, stress, intrusive and avoidant responses) of the COVID-19 pandemic and lockdown restrictions on patients with severe mental disorders (bipolar and psychotic disorders) in Spain.

We observed a higher anxiety response in our sample of people with SMD compared with HC. However, no different psychological reaction phenotype was identified between patients with SMD and patients with CMD after considering potential confounding factors. It should be noted that the people in each group were matched for age and sex, as well as geographical area, and that the temporal distribution of survey responses was similar among the three groups. Other differences detected in work and income status or living situation were taken into account for multivariate analyses.

Lockdown, isolation, and fear of infection are known to have a negative psychological impact on the global population (Brooks et al., 2020). People with previous physical illnesses, older adults, and patients with mental problems are especially vulnerable (García-Álvarez et al., 2020a), and we expect a differential psychological impact on people with severe mental disorders when facing a lockdown situation. Moreover, these patients may find themselves at a disadvantaged starting point because they tend to build poorer quality social networks (Green et al., 2018), and lower use of online and mobile technologies could further aggravate their isolation (Firth et al., 2016), which might also involve worse functional outcomes (Degnan et al., 2018). Previous studies in individuals with BD have reported a more significant impact of life events on their clinical course than in people with unipolar depression and suggested an increased number of life events before an acute mood episode in people with BD (Lex et al., 2017).

Surprisingly, we observed that a high percentage of people with SMD were able to cope with the first few weeks of the pandemic, with more than 85% being able to enjoy their free time. This strategy has also turned out to be a protective factor for anxiety in our study, as previously reported in García-Álvarez et al. (2020a) for the whole population. Furthermore, these people with SMD more frequently engaged in relaxing activities or meditation compared with those without a mental disorder, perhaps helped by dedicated activities in mental health facilities (Fibbins et al., 2018; Potes et al., 2018). However, it must be remarked that the patients in our sample, who required better digital literacy and motivation in order to participate in the survey, could also be those most proficient in engaging in leisure activities and thus more capable of enjoying their free time. Furthermore, a significant proportion of the SMD group (around 50%) consisted of people with a diagnosis of BD, which could explain the high percentage of people with a higher education, an active work status, and varied leisure activities.

In contrast, they use tobacco more frequently as a coping strategy in the current circumstances. It should be noted that higher smoking rates, as we might expect during the COVID-19 pandemic (García-Álvarez et al., 2020b), not only increase the risk of infection but have also been associated with worse prognosis if the illness develops (Druss, 2020).

One of the main results of the present study was that the COVID-19 outbreak was associated with a higher anxiety response in people with SMD. These findings are consistent with previous studies from the SARS epidemic, which reported higher levels of anxiety in inpatients with schizophrenia compared with the staff (Iancu et al., 2005), but this reaction was not more severe than in people with other common mental disorders in our sample. The existing literature found that anxiety, a frequent yet often neglected comorbidity in SMD (Buonocore et al., 2018), could lead to a worse prognosis in both BD (Corry et al., 2013; Spoorthy et al., 2019) and schizophrenia (Braga et al., 2013). While other people may be able to develop functional coping strategies to face this emotional reaction, anxiety could determine unfavorable outcomes in the vulnerable population with SMD, such as triggering a relapse (Druss, 2020). Moreover, anxiety could lead to pathological psychological responses, and there is some evidence for an increased number of suicides after previous pandemics (Chan et al., 2006).

Other impressive results from our study are that we found a higher anxiety response to the pandemic and lockdown in people with SMD who were not married, had symptoms of COVID-19, and presented a more severe stress response. With regard to marital status, our results contrast with those obtained in the population with a past mental disorder (García-Álvarez et al., 2020a), in which not being married was a protective factor for the anxiety response. Being married could represent a protective factor for functional impairment in patients with BD (Bonnín et al., 2019) and it is plausible that, in the current lockdown situation, married patients could be more protected from social isolation and more likely to receive emotional, psychosocial, or financial support if needed (Wingo et al., 2010). Another explanation could be that people with no family of their own had worse personal and social functioning at baseline, making them more vulnerable to the psychological impact of the COVID-19 outbreak.

During previous infectious outbreaks, patients reported higher anxiety levels (Maunder et al., 2003), and these dysfunctional reactions seem to be replicated in symptomatic COVID-19 patients, independent of previous mental health status (García-Álvarez et al., 2020a). Finally, it is not surprising that stress response and anxiety were strongly associated, since there may be a natural continuity between these domains (Corry et al., 2013). Among the sociodemographic factors, we did not find that older age or being female were risk factors for anxiety symptoms in the SMD group, while other authors have found in the general population that younger people and females were at higher risk of anxiety in the context of the pandemic (Wang et al., 2020a, Wang et al., 2020b).

In summary, our findings support previous research showing that anxiety is mainly determined by early environmental factors, as well as by socio-cognitive dimensions such as personal distress (Buonocore et al., 2018). Therefore, we stress the importance for clinicians to routinely assess anxiety responses in people with SMD, as they may represent an early sign of greater vulnerability to psychological distress due to the current lockdown situation. As our results reflect the impact of only the first few weeks of the COVID-19 pandemic, future research should focus on long-term psychological consequences, considering the possible distress due to loss of family members and caregivers as well as increasing rates of unemployment or homelessness.

However, the current study has certain limitations. Besides those already reported by García-Álvarez et al. (2020a) in terms of representativeness and selection bias of the sample, we should add the fact that people with psychosis have less access to digital technologies (Firth et al., 2016; Robotham et al., 2016). We assume that people with SMD who responded to the survey have greater access to these resources and, therefore, may not adequately represent the target population. This is also demonstrated by the higher percentage of people with SMD who have a university education (more than 50%). We should also mention that diagnoses were self-reported, and the diagnostic category for “psychosis” could include a broad spectrum of disorders, from single acute episodes to chronic disorders like schizophrenia. Moreover, we did not address the current state of patients who reported BD, nor the predominant polarity. Symptoms of depression, anxiety, or stress experienced by respondents were also collected from self-reported psychometric instruments, with the common drawbacks of such instruments. Also, the use of a binary response solution (“no” or yes”) instead of a Likert-type scale to rate behaviours could represent another limitation.

Even so, several strengths of the present study should be considered, such as its nationwide population-based design and the matching performed to compare three similar groups regarding sociodemographic variables. Moreover, it is essential to point out that, to our knowledge, this is the first study to provide information on the early psychological impact of the COVID-19 outbreak and lockdown measures on people with SMD.

5. Conclusions

In conclusion, in the current study, we provide the first pieces of evidence of the psychological impact of the early phase of the COVID-19 outbreak on people with severe mental disorders. Overall, our results show that these patients with psychotic or bipolar disorders reacted to the pandemic and the lockdown restrictions with higher anxiety than healthy controls. Furthermore, this response was associated with being single, having COVID-19 symptoms, being highly stressed, and having less ability to enjoy free time.

If replicated, these results could suggest the utility of anxiety, an often neglected but frequent symptom in this population, as a criterion for strategies of early intervention and closer follow-up in the months to come.

The following are the supplementary data related to this article.

Table 1

Geographical distribution of the study sample groups.

mmc1.pdf (193.6KB, pdf)

Authors' contributions

LGA, LFT, MPGP, PAS, and JB designed the study. All authors reviewed and approved it and acquired the data. LGB and FDS conducted the statistical analyses. LGB, FDS wrote the first draft of the manuscript. All authors reviewed all drafts and gave the final approval.

Role of the funding source

This work was partly supported by the Government of the Principality of Asturias PCTI-2018-2022 IDI/2018/235, the CIBERSAM, and Fondos Europeos de Desarrollo Regional (FEDER).

The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflict of interest for the submitted work.

Declaration of competing interest

The authors declare no conflict of interest for the submitted work.

Acknowledgments

The authors wish to thank Sharon Grevet for her English assistance and Fundación para la Investigación e Innovación Biosanitaria del Principado de Asturias (FINBA) for its financial support.

Biographies

graphic file with name fx1_lrg.jpg

Leticia González-Blanco, Specialist in Psychiatry (2016) and PhD in Medicine (2018) from the University of Oviedo. Extraordinary PhD Award. Assistant Professor in Health Sciences (Psychiatry) at the University of Oviedo and Psychiatrist at Mental Health Center of Corredoria (Oviedo). Researcher of the Centro de Investigación Biomédica en Red de Salud Mental -CIBERSAM, supported by the Spanish Ministry of Economy and Competitiveness, and of the Psychiatric Research Group of the Instituto de Investigación Sanitaria del Principado de Asturias (ISPA). Collaboration in National, European, WHO Research Projects, and linked as Co-Investigator to 2 FIS Projects. Interested in clinical research, focusing on schizophrenia and psychotic spectrum disorders.

graphic file with name fx2_lrg.jpg

Francesco Dal Santo, Bachelor of Medicine and Surgery (University of Padova, Italy) and Master's Degree in Mental Health Research (Complutense University of Madrid, Spain). Resident in Psychiatry (4th year) at the Hospital Universitario Central de Asturias (Oviedo, Spain) and Ph.D. student at the Department of Psychiatry of the University of Oviedo. Visiting researcher at University of Cambridge (2019). Interested in clinical research, focusing on cognition in people with schizophrenia and psychotic spectrum disorders.

graphic file with name fx3_lrg.jpg

Leticia García-Álvarez, Bachelor of Psychology (University of Oviedo) 2006, Master in Behavior Therapy (National University of Distance Education, UNED) 2010 and Master in Teacher Training (University of Nebrija) 2018. PhD in the department of Psychology (University of Oviedo) 2012 and in Health Sciences (University of Oviedo) 2016. Extraordinary Doctorate Award from the University of Oviedo and award for the best Doctoral Thesis in Other Medical Specialties by the Royal Academy of Medicine of the Principality of Asturias.

graphic file with name fx4_lrg.jpg

Lorena de la Fuente-Tomás is a postdoctoral researcher at the University of Oviedo. She obtained her degree in Psychology (2012) at the same university, and her Master in Research and Mental Health (2016) at the Complutense University of Madrid. She was awarded by “Severo Ochoa Grant” (2016–2019) to get her PhD under supervision of Prof. García-Portilla and Dr. García-Alvarez. She performed a three-month predoctoral stay at the Brain and Mind Sciences Department at Cambridge University (2018). She was awarded by the “Extraordinary PhD Award” by the Institute of Health Research of the Principality of Asturias (2020). She is co-author of more than 20 publications indexed in Pubmed in the last 4 years.

graphic file with name fx5_lrg.jpg

Carlota Moya Lacasa, Specialist in Psychiatry (2020) at Hospital Universitario Central de Asturias (Oviedo, Asturias), and PhD student in Health Sciences at the University of Oviedo. Research internship at the University of Nevada in the Department of Psychiatry and Behavioral Sciences (Reno, march-may 2019). Interested in clinical research, focused on bipolar disorder.

graphic file with name fx6_lrg.jpg

Gonzalo Paniagua, Bachelor of Medicine and Surgery (University of Cantabria 1996–2002), Specialist in Psychiatry (Hospital Universitario de Salamanca 2003–2007). University Expert in Bipolar Disorder (University Of Barcelona 2014). University Expert in Forensic Psychiatry (UNED 2009). Extensive clinical experience of more than 15 years in inpatients and outpatients of Mental Health, in Psychiatric Service of Hospital Central de Asturias, Oviedo, Spain.

graphic file with name fx7_lrg.jpg

Pilar A Sáiz, Clinical Biochemistry and Psychiatrist, is Professor of Psychiatry at the University of Oviedo, Spain, and also member of the Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), of the Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), and of the Instituto Universitario de Neurociencias del Principado de Asturias (INEUROPA). She has been involved in research of bio-psycho-social aspects of suicidal behavior and major mental disorders for over 25 years and she is co-author of several publications ranging from biological aspects to psycho-social correlates of those disorders.

graphic file with name fx8_lrg.jpg

María Paz García-Portilla is currently Professor of Psychiatry at the University of Oviedo (Spain) and responsible for the Mental Health Center of La Eria (Oviedo) with a catchment area of more than 80,000 people. I am co-principal investigator of the Group 05 (University of Oviedo) of the Centro de Investigación Biomédica en Red de Salud Mental -CIBERSAM, supported by the Spanish Ministry of Economy and Competitiveness, and of the Psychiatric Research Group of the Instituto de Investigación Sanitaria del Principado de Asturias (ISPA). My areas of interest are severe mental disorders, mainly schizophrenia and bipolar disorders, and I am co-author of more than 125 papers in peer-reviewed journals.

graphic file with name fx9_lrg.jpg

Julio Bobes, Professor of Psychiatry at the University of Oviedo, currently headsthe Psychiatry Area of the Department of Medicine of the University and is Head of the Psychiatry Department of the Sanitary Area of Oviedo. He is the principal investigator of the Center for Biomedical Research in Mental Health Network (CIBERSAM) of Oviedo. He has published more than 100 articles and is the author and coordinator of several books, as well as a contributor to numerous chapters. His research interests include different aspects of the evaluation, management, treatment and impact of different psychiatric disorders.

References

  1. Bados A., Solanas A., Andrés R. Psychometric properties of the Spanish version of Depression, Anxiety and Stress Scales (DASS) Psicothema. 2005;17:679–683. [Google Scholar]
  2. Báguena M., Villaroya E., Beleña A., Díaz A., Reig R. Propiedades Psicométricas de la Versión Española de la escala Revisada de Impacto del Estresor. An. Modif. Conduct. 2001;27:581–604. [Google Scholar]
  3. Bonnín C.D.M., Reinares M., Martínez-Arán A., Jiménez E., Sánchez-Moreno J., Solé B., Montejo L., Vieta E. Improving functioning, quality of life, and well-being in patients with bipolar disorder. Int. J. Neuropsychopharmacol. 2019;22:467–477. doi: 10.1093/ijnp/pyz018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Braga R.J., Reynolds G.P., Siris S.G. Anxiety comorbidity in schizophrenia. Psychiatry Res. 2013;210:1–7. doi: 10.1016/j.psychres.2013.07.030. [DOI] [PubMed] [Google Scholar]
  5. Brooks S.K., Webster R.K., Smith L.E., Woodland L., Wessely S., Greenberg N., Rubin G.J. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020;395:912–920. doi: 10.1016/S0140-6736(20)30460-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brown E., Gray R., Lo Monaco S., O'Donoghue B., Nelson B., Thompson A., Francey S., McGorry P. The potential impact of COVID-19 on psychosis: a rapid review of contemporary epidemic and pandemic research. Schizophr. Res. 2020 doi: 10.1016/j.schres.2020.05.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Buonocore M., Bosia M., Baraldi M.A., Bechi M., Spangaro M., Cocchi F., Bianchi L., Guglielmino C., Mastromatteo A.R., Cavallaro R. Exploring anxiety in schizophrenia: new light on a hidden figure. Psychiatry Res. 2018;268:312–316. doi: 10.1016/j.psychres.2018.07.039. [DOI] [PubMed] [Google Scholar]
  8. Chan S.M.S., Chiu F.K.H., Lam C.W.L., Leung P.Y.V., Conwell Y. Elderly suicide and the 2003 SARS epidemic in Hong Kong. Int. J. Geriatr. Psychiatry. 2006;21:113–118. doi: 10.1002/gps.1432. [DOI] [PubMed] [Google Scholar]
  9. Corry J., Green M., Roberts G., Frankland A., Wright A., Lau P., Loo C., Breakspear M., Mitchell P.B. Anxiety, stress and perfectionism in bipolar disorder. J. Affect. Disord. 2013;151:1016–1024. doi: 10.1016/j.jad.2013.08.029. [DOI] [PubMed] [Google Scholar]
  10. Degnan A., Berry K., Sweet D., Abel K., Crossley N., Edge D. Social networks and symptomatic and functional outcomes in schizophrenia: a systematic review and meta-analysis. Soc. Psychiatry Psychiatr. Epidemiol. 2018;53:873–888. doi: 10.1007/s00127-018-1552-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Druss B.G. Addressing the COVID-19 pandemic in populations with serious mental illness. JAMA Psychiatry. 2020 doi: 10.1001/jamapsychiatry.2020.0894. [DOI] [PubMed] [Google Scholar]
  12. Fibbins H., Ward P.B., Watkins A., Curtis J., Rosenbaum S. Improving the health of mental health staff through exercise interventions: a systematic review. J. Ment. Health. 2018;27:184–191. doi: 10.1080/09638237.2018.1437614. [DOI] [PubMed] [Google Scholar]
  13. Firth J., Cotter J., Torous J., Bucci S., Firth J.A., Yung A.R. Mobile phone ownership and endorsement of "mHealth" among people with psychosis: a meta-analysis of cross-sectional studies. Schizophr. Bull. 2016;42:448–455. doi: 10.1093/schbul/sbv132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Fusar-Poli P., Tantardini M., De Simone S., Ramella-Cravaro V., Oliver D., Kingdon J., Kotlicka-Antczak M., Valmaggia L., Lee J., Millan M.J., Galderisi S., Balottin U., Ricca V., McGuire P. Deconstructing vulnerability for psychosis: meta-analysis of environmental risk factors for psychosis in subjects at ultra high-risk. Eur. Psychiatry. 2017;40:65–75. doi: 10.1016/j.eurpsy.2016.09.003. [DOI] [PubMed] [Google Scholar]
  15. García-Álvarez, L., de la Fuente-Tomás, L., García-Portilla, M. P., Sáiz, P. A., Moya Lacasa, C., Dal Santo, F., … Bobes, J., 2020a. Early psychological impact of the 2019 coronavirus disease (COVID-19) pandemic and lockdown in a large Spanish sample. J. Glob. Health [In press]. [DOI] [PMC free article] [PubMed]
  16. García-Álvarez L., Fuente-Tomas L.D. la, Saiz P.A., Garcia-Portilla M., Feminine P., Bobes J. Will changes in alcohol and tobacco use be seen during the COVID-19 lockdown? Adicciones. 2020 doi: 10.20882/adicciones.1546. [DOI] [PubMed] [Google Scholar]
  17. Green M.F., Horan W.P., Lee J., McCleery A., Reddy L.F., Wynn J.K. Social disconnection in schizophrenia and the general community. Schizophr. Bull. 2018;44:242–249. doi: 10.1093/schbul/sbx082. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Iancu I., Strous R., Poreh A., Kotler M., Chelben Y. Psychiatric inpatients' reactions to the SARS epidemic: an Israeli survey. Isr. J. Psychiatry Relat. Sci. 2005;42:258–262. [PubMed] [Google Scholar]
  19. Kozloff N., Mulsant B.H., Stergiopoulos V., Voineskos A.N. The COVID-19 global pandemic: implications for people with schizophrenia and related disorders. Schizophr. Bull. 2020 doi: 10.1093/schbul/sbaa051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lam M.H.-B., Wing Y.-K., Yu M.W.-M., Leung C.-M., Ma R.C.W., Kong A.P.S., So W.Y., Fong S.Y.-Y., Lam S.-P. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch. Intern. Med. 2009;169:2142–2147. doi: 10.1001/archinternmed.2009.384. [DOI] [PubMed] [Google Scholar]
  21. Lex C., Bäzner E., Meyer T.D. Does stress play a significant role in bipolar disorder? A meta-analysis. J. Affect. Disord. 2017;208:298–308. doi: 10.1016/j.jad.2016.08.057. [DOI] [PubMed] [Google Scholar]
  22. Lima C.K.T., Carvalho P.M. de M., Lima I. de A.A.S., Nunes J.V.A. de O., Saraiva J.S., de Souza R.I., da Silva C.G.L., Neto M.L.R. The emotional impact of Coronavirus 2019-nCoV (new Coronavirus disease) Psychiatry Res. 2020 doi: 10.1016/j.psychres.2020.112915. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Maunder R., Hunter J., Vincent L., Bennett J., Peladeau N., Leszcz M., Sadavoy J., Verhaeghe L.M., Steinberg R., Mazzulli T. The immediate psychological and occupational impact of the 2003 SARS outbreak in a teaching hospital. CMAJ. 2003;168:1245–1251. [PMC free article] [PubMed] [Google Scholar]
  24. Pfefferbaum B., North C.S. Mental health and the Covid-19 pandemic. N. Engl. J. Med. 2020 doi: 10.1056/NEJMp2008017. [DOI] [PubMed] [Google Scholar]
  25. Potes A., Souza G., Nikolitch K., Penheiro R., Moussa Y., Jarvis E., Looper K., Rej S. Mindfulness in severe and persistent mental illness: a systematic review. Int. J. Psychiatry Clin. Pract. 2018;22:253–261. doi: 10.1080/13651501.2018.1433857. [DOI] [PubMed] [Google Scholar]
  26. Robotham D., Satkunanathan S., Doughty L., Wykes T. Do we still have a digital divide in mental health? A five-year survey follow-up. J. Med. Internet Res. 2016;18:e309. doi: 10.2196/jmir.6511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Spoorthy M.S., Chakrabarti S., Grover S. Comorbidity of bipolar and anxiety disorders: an overview of trends in research. World J. Psychiatry. 2019;9:7–29. doi: 10.5498/wjp.v9.i1.7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Wang C., Horby P.W., Hayden F.G., Gao G.F. A novel coronavirus outbreak of global health concern. Lancet. 2020;395:470–473. doi: 10.1016/S0140-6736(20)30185-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Wang Y., Di Y., Ye J., Wei W. Study on the public psychological states and its related factors during the outbreak of coronavirus disease 2019 (COVID-19) in some regions of China. Psychol. Health Med. 2020:1–10. doi: 10.1080/13548506.2020.1746817. [DOI] [PubMed] [Google Scholar]
  30. Wingo A.P., Baldessarini R.J., Holtzheimer P.E., Harvey P.D. Factors associated with functional recovery in bipolar disorder patients. Bipolar Disord. 2010;12:319–326. doi: 10.1111/j.1399-5618.2010.00808.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. World Medical Association General Assembly. Declaration of Helsinki, Ethical Principles for Medical Research Involving Human Subjects. Fortaleza, Brasil: Copyright, World Medical Association. 2013. Retrieved from: https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Table 1

Geographical distribution of the study sample groups.

mmc1.pdf (193.6KB, pdf)

Articles from Schizophrenia Research are provided here courtesy of Elsevier

RESOURCES